Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Wilfred K. H. Dinesen"'
Autor:
Line Uhrenholt, Robin Christensen, Wilfred K H Dinesen, Caroline H Liboriussen, Stine S Andersen, Lene Dreyer, Annette Schlemmer, Ellen-Margrethe Hauge, Conni Skrubbeltrang, Peter C Taylor, Salome Kristensen
Publikováno v:
Uhrenholt, L, Christensen, R, Dinesen, W K H, Liboriussen, C H, Andersen, S S, Dreyer, L, Schlemmer, A, Hauge, E-M, Skrubbeltrang, C, Taylor, P C & Kristensen, S 2022, ' Risk of flare after tapering or withdrawal of biologic/targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis or axial spondyloarthritis : a systematic review and meta-analysis ', Rheumatology, vol. 61, no. 8, pp. 3107-3122 . https://doi.org/10.1093/rheumatology/keab902
Uhrenholt, L, Christensen, R, Dinesen, W K H, Liboriussen, C H, Andersen, S S, Dreyer, L, Schlemmer, A, Hauge, E-M, Skrubbeltrang, C, Taylor, P C & Kristensen, S 2022, ' Risk of flare after tapering or withdrawal of biologic/targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis or axial spondyloarthritis : A systematic review and meta-analysis ', Rheumatology, vol. 61, no. 8, pp. 3107–3122 . https://doi.org/10.1093/rheumatology/keab902
Uhrenholt, L, Christensen, R, Dinesen, W K H, Liboriussen, C H, Andersen, S S, Dreyer, L, Schlemmer, A, Hauge, E-M, Skrubbeltrang, C, Taylor, P C & Kristensen, S 2022, ' Risk of flare after tapering or withdrawal of biologic/targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis or axial spondyloarthritis : A systematic review and meta-analysis ', Rheumatology, vol. 61, no. 8, pp. 3107–3122 . https://doi.org/10.1093/rheumatology/keab902
Objective To evaluate flare risk when tapering or withdrawing biologic or targeted synthetic DMARDs (bDMARDs or tsDMARDs) compared with continuation in patients with inflammatory arthritis in sustained remission or with low disease activity. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1773c0a67e86ba7e2f9238c06b2aa062
https://pure.au.dk/portal/da/publications/risk-of-flare-after-tapering-or-withdrawal-of-biologictargeted-synthetic-diseasemodifying-antirheumatic-drugs-in-patients-with-rheumatoid-arthritis-or-axial-spondyloarthritis(69ca9bb0-bcb1-4219-9dd9-166484032d04).html
https://pure.au.dk/portal/da/publications/risk-of-flare-after-tapering-or-withdrawal-of-biologictargeted-synthetic-diseasemodifying-antirheumatic-drugs-in-patients-with-rheumatoid-arthritis-or-axial-spondyloarthritis(69ca9bb0-bcb1-4219-9dd9-166484032d04).html
Autor:
Tobias Eschricht Eriksen, Wilfred K. H. Dinesen, Line Uhrenholt, Lene Dreyer, Kirsten Duch, Salome Kristensen
Publikováno v:
Eriksen, T E, Dinesen, W K H, Uhrenholt, L, Dreyer, L, Duch, K & Kristensen, S 2022, ' Isolation in patients with inflammatory rheumatic diseases during COVID-19 pandemic compared to healthy individuals : a questionnaire survey ', Rheumatology International, vol. 42, no. 5, pp. 783-790 . https://doi.org/10.1007/s00296-022-05111-6
As a result of the pandemic, many patients with an inflammatory rheumatic disease (IRD) have isolated themselves. The lack of disease management together with fear of infection could lead to changes in physical- and mental health. The aim of this stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dde864349bb88bde684bcf811b933907
https://vbn.aau.dk/da/publications/e8f15a12-cc15-4793-83dd-10f7a8ef1f42
https://vbn.aau.dk/da/publications/e8f15a12-cc15-4793-83dd-10f7a8ef1f42